 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Atara Biotherapeutics Inc. (ATRA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-27 Sale | 2019-09-30 4:25 pm | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 3,500 | $13.51 | $47,285 | 57,998 (Direct) | View |
| 2019-06-27 Purchase | 2019-07-01 5:01 pm | Atara Biotherapeutics Inc. | ATRA | DOBMEIER ERIC Director | 2,000 | $19.5 | $39,000 | 20,000 (Direct) | View |
| 2019-05-29 Sale | 2019-05-31 4:16 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 5,850 | $23.09 | $135,089 | 332,243 (Direct Indirect) | View |
| 2019-05-13 Sale | 2019-05-15 4:35 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 7,800 | $24.61 | $191,973 | 332,243 (Direct Indirect) | View |
| 2019-05-06 Sale | 2019-05-07 4:31 pm | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $35 | $52,500 | 65,000 (Direct) | View |
| 2019-04-25 Sale | 2019-04-29 5:36 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 7,800 | $33.54 | $261,582 | 332,243 (Direct Indirect) | View |
| 2019-04-10 Sale | 2019-04-12 4:19 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 7,800 | $36.66 | $285,909 | 332,243 (Direct Indirect) | View |
| 2019-04-01 Sale | 2019-04-03 7:22 pm | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $39.96 | $59,940 | 66,500 (Direct) | View |
| 2019-03-28 Sale | 2019-04-01 4:16 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 7,800 | $38.66 | $301,546 | 332,243 (Direct Indirect) | View |
| 2019-02-01 Sale(A) | 2019-04-01 4:16 pm | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 500 | $38.44 | $19,220 | 31,858 (Direct) | View |
| 2019-03-15 Sale | 2019-03-19 4:19 pm | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 20,000 | $38.25 | $765,000 | 888,355 (Indirect Direct) | View |
| 2019-03-14 Sale | 2019-03-18 4:13 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 7,800 | $39.48 | $307,953 | 334,837 (Direct Indirect) | View |
| 2019-03-01 Sale | 2019-03-05 6:58 pm | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $36.13 | $54,202 | 68,000 (Direct) | View |
| 2019-02-27 Sale | 2019-03-01 4:10 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 7,800 | $36.14 | $281,891 | 343,137 (Direct Indirect) | View |
| 2019-02-27 Sale | 2019-03-01 4:09 pm | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 62,590 | $36.07 | $2,257,621 | 908,355 (Indirect Direct) | View |
| 2019-02-15 Sale | 2019-02-19 5:08 pm | Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP R&D & Chief Scientific Of | 775 | $39.59 | $30,682 | 271,943 (Indirect Direct) | View |
| 2019-02-15 Sale | 2019-02-19 5:05 pm | Atara Biotherapeutics Inc. | ATRA | Porter Derrell VP | 5,909 | $40 | $236,360 | 109,666 (Direct) | View |
| 2019-02-09 Sale | 2019-02-12 7:18 pm | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 7,800 | $38.76 | $302,367 | 346,038 (Indirect Direct) | View |
| 2019-02-11 Sale | 2019-02-11 7:10 pm | Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP R&D & Chief Scientific Of | 13,975 | $38.55 | $538,736 | 272,718 (Indirect Direct) | View |
| 2019-02-06 Sale | 2019-02-08 4:28 pm | Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP R&D & Chief Scientific Of | 12,375 | $38.62 | $477,922 | 286,693 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-27 Option Award | 2019-07-01 5:58 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director | 4,000 | $0 | 1,822,228 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:58 pm | N/A 2029-06-26 | Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director | 13,000 | $20.25 | 1,822,228 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:01 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | DOBMEIER ERIC Director | 4,000 | $0 | 20,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:01 pm | N/A 2029-06-26 | Atara Biotherapeutics Inc. | ATRA | DOBMEIER ERIC Director | 13,000 | $20.25 | 20,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:00 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director | 4,000 | $0 | 92,818 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:00 pm | N/A 2029-06-26 | Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director | 13,000 | $20.25 | 92,818 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:00 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 4,000 | $0 | 25,854 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:00 pm | N/A 2029-06-26 | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 13,000 | $20.25 | 25,854 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:59 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | HEIDEN WILLIAM K Director | 4,000 | $0 | 13,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:59 pm | N/A 2029-06-26 | Atara Biotherapeutics Inc. | ATRA | HEIDEN WILLIAM K Director | 13,000 | $20.25 | 13,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:58 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director | 4,000 | $0 | 13,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:58 pm | N/A 2029-06-26 | Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director | 13,000 | $20.25 | 13,000 (Direct) | View |
| 2019-06-24 Option Award | 2019-06-25 4:20 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Touchon Pascal CEO | 140,074 | $0 | 225,000 (Direct) | View |
| 2019-06-24 Option Award | 2019-06-25 4:20 pm | N/A 2029-06-24 | Atara Biotherapeutics Inc. | ATRA | Touchon Pascal CEO | 225,000 | $20.43 | 225,000 (Direct) | View |
| 2019-05-07 Tax Withholding | 2019-05-08 4:32 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Berger Dietmar Global Head of R&D | 4,322 | $33.46 | 85,678 (Direct) | View |
| 2019-05-06 Exercise | 2019-05-07 4:31 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $20.4 | 65,000 (Direct) | View |
| 2019-05-06 Exercise | 2019-05-07 4:31 pm | N/A 2024-04-03 | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $20.4 | 65,000 (Direct) | View |
| 2019-04-09 Tax Withholding | 2019-04-10 4:33 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Kim Mina VP | 3,674 | $36.85 | 66,389 (Direct) | View |
| 2019-04-01 Exercise | 2019-04-03 7:22 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $20.4 | 66,500 (Direct) | View |
| 2019-04-01 Tax Withholding | 2019-04-03 7:22 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 648 | $41.04 | 66,500 (Direct) | View |
| 2019-04-01 Exercise | 2019-04-03 7:22 pm | N/A 2024-04-03 | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $20.4 | 66,500 (Direct) | View |
| 2019-03-26 Option Award | 2019-03-27 5:19 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal CFO | 10,000 | $0 | 74,063 (Direct) | View |
| 2019-03-26 Option Award | 2019-03-27 5:18 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Kim Mina VP | 10,000 | $0 | 70,063 (Direct) | View |
| 2019-03-26 Option Award | 2019-03-27 5:18 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 15,000 | $0 | 62,146 (Direct) | View |
| 2019-03-26 Option Award | 2019-03-27 5:17 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Berger Dietmar Global Head of R&D | 15,000 | $0 | 90,000 (Direct) | View |
| 2019-03-26 Option Award | 2019-03-27 5:17 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Porter Derrell VP | 10,000 | $0 | 31,688 (Direct) | View |
| 2019-03-01 Exercise | 2019-03-05 6:58 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $20.4 | 68,000 (Direct) | View |
| 2019-03-01 Exercise | 2019-03-05 6:58 pm | N/A 2024-04-03 | Atara Biotherapeutics Inc. | ATRA | Newell Joe COO | 1,500 | $20.4 | 68,000 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 25,000 | $25.15 | 908,355 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 10,500 | $24.05 | 908,355 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 5,500 | $15.08 | 908,355 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 21,500 | $13.2 | 908,355 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A 2022-01-16 | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 25,000 | $25.15 | 908,355 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A 2023-01-04 | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 10,500 | $24.05 | 908,355 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A 2024-01-03 | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 5,500 | $15.08 | 908,355 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-01 4:09 pm | N/A 2024-06-08 | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 21,500 | $13.2 | 908,355 (Direct) | View |
| 2018-06-14 Option Award | 2019-03-01 4:08 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 1,500 | $0 | 908,355 (Direct) | View |
| 2018-06-14 Option Award | 2019-03-01 4:08 pm | N/A 2025-06-13 | Atara Biotherapeutics Inc. | ATRA | MARCUS JOEL S Director | 5,000 | $45.65 | 908,355 (Direct) | View |
| 2019-02-15 Tax Withholding | 2019-02-19 5:06 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 1,176 | $40.45 | 343,337 (Direct) | View |
| 2019-02-15 Exercise | 2019-02-19 5:05 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Porter Derrell VP | 4,000 | $14.3 | 109,666 (Direct) | View |
| 2019-02-15 Exercise | 2019-02-19 5:05 pm | N/A 2024-05-10 | Atara Biotherapeutics Inc. | ATRA | Porter Derrell VP | 4,000 | $14.3 | 109,666 (Direct) | View |
| 2019-02-09 Tax Withholding | 2019-02-12 7:18 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 20,324 | $38.49 | 346,038 (Direct) | View |
| 2019-02-06 Tax Withholding | 2019-02-12 7:17 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 24,683 | $38.47 | 375,611 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:44 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal CFO | 17,063 | $0 | 64,063 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:44 pm | N/A 2029-02-05 | Atara Biotherapeutics Inc. | ATRA | Koppikar Utpal CFO | 34,125 | $38.47 | 64,063 (Direct) | View |
| 2019-02-06 Tax Withholding | 2019-02-08 4:28 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP R&D & Chief Scientific Of | 1,512 | $38.47 | 286,693 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:28 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP R&D & Chief Scientific Of | 15,000 | $0 | 286,693 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:28 pm | N/A 2029-02-05 | Atara Biotherapeutics Inc. | ATRA | Haqq Christopher EVP R&D & Chief Scientific Of | 30,000 | $38.47 | 286,693 (Direct) | View |
| 2019-02-06 Tax Withholding | 2019-02-08 4:27 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Ciechanover Isaac E. CEO | 24,683 | $0 | 375,611 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:26 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Berger Dietmar Global Head of R&D | 25,000 | $0 | 75,000 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:26 pm | N/A 2029-02-05 | Atara Biotherapeutics Inc. | ATRA | Berger Dietmar Global Head of R&D | 50,000 | $38.47 | 75,000 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:25 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Kim Mina VP | 17,063 | $0 | 60,063 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:25 pm | N/A 2029-02-05 | Atara Biotherapeutics Inc. | ATRA | Kim Mina VP | 34,125 | $38.47 | 60,063 (Direct) | View |
| © 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 Sat, 16 Nov 2019 16:22:55 -0600 | SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |